Athens – November 12 2007 – Coca‑Cola Hellenic Bottling Company S.A. (Coca‑Cola HBC, CCHBC) announced that it has signed a letter of intent with The Coca‑Cola Company which will allow the formation of a three way joint venture with illycaffè SpA. The joint venture will be responsible for the manufacture, marketing, selling and distribution of premium ready-to-drink coffee across Coca‑Cola HBC’s territories.

This follows the announcement by The Coca‑Cola Company and illycaffè in October of this year of their intention to establish a global joint venture.

It is expected that negotiations in relation to the joint venture business model, which will also be subject to regulatory approval, will be concluded in early 2008.

Commenting, Doros Constantinou, Managing Director of CCHBC said, “Ready-to-drink coffee is a small but high growth high value category in most of our markets. The formation of this joint venture will combine the strengths of the Coca‑Cola System around marketing, customer relationships, and route-to market capabilities with illy a premium coffee brand. Furthermore, this joint venture will further strengthen our premium product offering and will allow us to maximise its potential working with two very strong partners who share the same vision as ourselves.”


Company contacts:

Coca‑Cola HBC

Melina Androutsopoulou

Investor Relations Director


George Toulantas

Investor Relations Manager




Tel: +30 210 618 3229



Tel: +30 210 618 3255

email :

European press contact:

Financial Dynamics London

Greg Quine


Tel: +44 20 7269 7206


US press contact:

Financial Dynamics US

Jim Olecki


Tel: +1 212 850 5600


Coca‑Cola HBC’s website is located at

Coca‑Cola HBC is one of the world's largest bottlers of products of The Coca‑Cola Company and has operations in 28 countries serving a population of 540 million people. CCHBC shares are listed on the Athens Exchange (ATHEX: EEEK), with secondary listings on the London (LSE: CCB) and Australian (ASX: CHB) Stock Exchanges. CCHBC’s American Depositary Receipts (ADRs) are listed on the New York Stock Exchange (NYSE: CCH).